AN1 0.00% 0.8¢ anagenics limited

Ann: Appendix 4C and Notes to Appendix 4C, page-7

  1. 546 Posts.
    lightbulb Created with Sketch. 131
    @tomchena I wouldn't say it's a question mark as much as it's perhaps not as imminent as some may have expected. But I for one am pleased that the reason they've not achieved cash flow positivity or more of a move towards profitability in this quarter is largely due to a significant increase in production costs. As stated, they are ramping up production to increase inventory and meet the emerging demand, and this goes a long way to quelling my primary fear for the retail side, which was that of over-trading.

    Ally that to the quiet confidence on midkine, and this has all the hallmarks of a very strong year on the horizon, IMO. DYOR
    Last edited by macda: 30/01/20
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.